Cumberland Pharmaceuticals (CPIX) Change in Receivables (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Change in Receivables of -$2.7 million for Q1 2026, down 141.18% sequentially from $6.5 million in Q4 2025, and down 121.07% YoY from $12.7 million in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Change in Receivables (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Change in Receivables for 17 years, with the latest figure at -$2.7 million in Q1 2026.
- Quarterly Change in Receivables fell 121.07% year-over-year to -$2.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (up 1221.02% YoY) and the FY2025 annual result came in at $5.2 million, up 169.82% from the prior year.
- Change in Receivables slipped to -$2.7 million in Q1 2026 per CPIX's latest filing, from $6.5 million in the prior quarter.
- Over five years, Change in Receivables peaked at $7.8 million in Q1 2022 and troughed at -$2.7 million in Q1 2026.
- A 5-year average of $424381.9 and a median of -$171014.0 in 2025 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2022 and 2024: Change in Receivables surged 4421.45% in 2022, then slumped 666.56% in 2024.
- Over 5 years, Change in Receivables stood at -$2.1 million in 2022, then fell by 21.54% to -$2.5 million in 2023, then surged by 115.54% to $390841.0 in 2024, then jumped by 1566.71% to $6.5 million in 2025, then slumped by 141.18% to -$2.7 million in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered -$2.7 million, $6.5 million, and $113691.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.47 Bn | 43.51 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.72 Bn | 40.07 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 32.45 Bn | 30.77 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 21.99 Bn | 19.32 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 19.01 Bn | 18.13 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.98 Bn | 11.45 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 112.06 Mn | 108.20 Mn | - | -842,384.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -842,384.00 |
| Jun 30, 2026 | -842,384.00 |
| Mar 31, 2026 | -2.68 Mn |
| Mar 31, 2026 | -2.68 Mn |
| Dec 31, 2025 | 6.51 Mn |
| Dec 31, 2025 | 6.51 Mn |
| Sep 30, 2025 | 113,691.00 |
| Sep 30, 2025 | 113,691.00 |
| Jun 30, 2025 | -171,014.00 |
| Jun 30, 2025 | -171,014.00 |
| Mar 31, 2025 | -1.21 Mn |
| Mar 31, 2025 | -1.21 Mn |
| Dec 31, 2024 | 390,841.00 |
| Dec 31, 2024 | 390,841.00 |
| Sep 30, 2024 | -309,138.00 |
| Sep 30, 2024 | -309,138.00 |
| Jun 30, 2024 | 795,177.00 |
| Jun 30, 2024 | 795,177.00 |
| Mar 31, 2024 | 1.07 Mn |
| Mar 31, 2024 | 1.07 Mn |